Shikha Gupta, MD
Allergy & Immunology · Lakewood, CONPI 1396127833
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $8,782 of the $11,716 with a category attached, or 75.0%. It is spread thinly across 22 manufacturers, the largest accounting for just 22.1%. 2025 is the largest year on record at $5,419, 5.3 times the $1,025 reported in 2019.
Across 313 payments — averaging $37.43 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Sanofi$3K
- GSK$2K
- Genentech USA, Inc.$2K
- AstraZeneca$2K
- Regeneron Healthcare Solutions, Inc.$938
- Genentech, Inc.$398
- plus $2K from 16 others
Across 1 payment — averaging $264.50 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- GSK$265
What the payments were for
- Consulting fees$2,79624%
- Food & beverage$8,78275%
- Education$1381%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Sanofi | 30 | $2,594 |
| GSK | 79 | $2,418 |
| Genentech USA, Inc. | 36 | $1,956 |
| AstraZeneca | 49 | $1,501 |
| Regeneron Healthcare Solutions, Inc. | 55 | $938 |
| Genentech, Inc. | 4 | $398 |
| Pharming Healthcare, Inc. | 5 | $304 |
| Novartis | 11 | $263 |
| Takeda Pharmaceuticals U.S.A., Inc. | 9 | $193 |
| Amgen | 4 | $191 |
| Octapharma USA, Inc. | 1 | $155 |
| Biocryst US Sales Co., LLC | 7 | $151 |
| Blueprint Medicines Corporation | 2 | $146 |
| Teva Pharmaceuticals USA, Inc. | 1 | $135 |
| Grifols USA, LLC | 5 | $115 |
| CSL Behring | 5 | $98 |
| Kaleo, Inc. | 2 | $35 |
| Galderma Laboratories, L.p. | 2 | $33 |
| ARS Pharmaceuticals Operations, Inc. | 1 | $29 |
| Organon | 3 | $24 |
| Lilly USA, LLC | 1 | $23 |
| AbbVie | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$11,716 in reported general payments places this provider in the 75th percentile of 89 allergy & immunology providers in Colorado.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 63 | $64,084 |
| Breo ElliptaFluticasone/Vilanterol | 11 | $10,035 |
| Fluticasone-SalmeterolFluticasone Propion/Salmeterol | 14 | $1,250 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 34 | $942 |
| Montelukast Sodium | 49 | $848 |
| Prednisone | 21 | $45 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| GSKTrelegy Ellipta, Breo Ellipta | $2,418 | $74,11974 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 89 allergy & immunology providers in Colorado.
Other allergy & immunology in Lakewood
- Nicole BarberisLakewood$351K
- Jeffrey RumbyrtLakewood$348K
- Paul SchkadeLakewood$52K
- Ross PalisLakewood$6K
- Kara CrosbyLakewood$3K
- Jagadish BoggavarapuLakewood$3K
- Rohit KatialDenver$758K
- Christopher WebberColorado Springs$350K
- Eric CaplanColorado Springs$290K
- Eileen WangDenver$274K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.